Georgia Charkoftaki, PharmD, PhD

Georgia Charkoftaki received her pharmacy degree from the University of Athens, Greece, where she also earned a MSc in drug delivery and a PhD in biopharmaceutics-pharmacokinetics. In August 2013 she moved to UC Denver to start a postdoc in clinical and translational science, focusing on kidney related diseases. Charkoftaki studied the pharmacokinetics of cyclophosphamide in patients undergoing dialysis and how Vitamin D affects drug metabolism in the kidneys, among other projects. At Yale, she has focused on bile acids and their mechanisms, acting as neuromodulators in alcoholism and neurodevelopmental disorders, as well as studying the role of aldehyde dehydrogenases (ALDHs) in neurodevelopmental disorders. She is leveraging her expertise in mass spectrometry-based omics approaches including metabolomics, lipidomics, and utilizing tissue imaging mass spectrometry (IMS) with a special focus on MALDI.